Hospital-acquired Infections (HAIs) represent a significant global health concern, posing pronounced challenges especially in developing nations. This analysis sheds light on the prevalence of HAIs over a period of six years in forty-two Chinese hospitals located in Weifang. Regulated by the Ministry of Health of the People’s Republic of China, cross-sectional surveys, taking place annually from 2015 to 2020, were conducted to collect data on HAIs. The information gathered included prevalence rates, the types of pathogens discovered, and the usage of antibiotics. The result demonstrated a marginal decrease in HAIs’ prevalence from 1.84% in 2015, to 1.55% in 2020.
The Intensive Care Units (ICUs) reported the highest prevalence of HAIs at 19.04%. Lower respiratory tract infections constituted roughly 46.32% of all reported cases. A total of 1,297 bacterial isolates were identified over this course, with Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli topping the list of most frequently found pathogens. Alarmingly, the most frequently detected resistant pathogen was the Carbapenem-Resistant Enterobacteriaceae. Despite the overall downward trend in HAIs across these hospitals, the challenge of controlling healthcare-associated pathogens and the inhibitors of multi-drug resistance remains a significant priority.
HAIs often develop in patients during their healthcare facility stay, often emerging more than 48 hours post-admission. These infections are typically triggered by different pathogens, including bacteria, fungi, and viruses. A critical health challenge posed by HAIs is that they potentially complicate treatment decisions and amplify public health challenges. Their occurrence is aggravated by the misuse of antibiotics and the emergency of drug-resistant pathogens.
This investigation provides a comprehensive six-year retrospective review of HAIs in 42 hospitals located in Weifang, China. The aim is to equip healthcare experts with insightful epidemiological characteristics – current trends, and antibiotic resistance patterns. This knowledge can be leveraged to enhance healthcare quality, improve disease monitoring and shape early warning systems. Future interventions should be geared towards comprehensive and integrated strategies that reduce the prevalence of HAIs, focus on essential HAI monitoring and commit to the rational use of antimicrobial agents.
Source: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-025-11046-7